- The report primarily focuses on tracking and analyzing market data of major broad-based indices in the A-share market, including their performance, turnover rates, risk premiums, PE-TTM values, dividend yields, and price-to-book ratios [1][3][5] - Turnover rates for major indices on March 30, 2026, were as follows: CSI 2000 (3.73), CSI 1000 (2.62), ChiNext Index (2.2), CSI 500 (1.77), CSI All Share (1.73), CSI 300 (0.63), and SSE 50 (0.29). The calculation method for turnover rate is: Σ(component stock circulating shares * component stock turnover rate) / Σ(component stock circulating shares [20] - Risk premiums relative to the 10-year government bond yield were observed for major indices. CSI 500 (56.83%) and CSI 1000 (56.35%) had relatively high 5-year percentile values, while CSI 300 (40.87%) and ChiNext Index (33.02%) were lower [31][33][36] - PE-TTM values and their historical percentiles were analyzed. CSI 500 (95.7%) and CSI All Share (94.96%) had high 5-year percentile values, while SSE 50 (76.03%) and ChiNext Index (57.36%) were lower. Current PE-TTM values were: SSE 50 (11.29), CSI 300 (13.96), CSI 500 (35.25), CSI 1000 (47.10), CSI 2000 (157.68), CSI All Share (21.64), and ChiNext Index (40.76) [39][43][44] - Dividend yields were tracked, showing current values as follows: SSE 50 (3.44%), CSI 300 (2.84%), CSI 500 (1.35%), CSI 1000 (1.05%), CSI 2000 (0.74%), CSI All Share (2.03%), and ChiNext Index (0.87%). Historical 5-year percentiles were highest for ChiNext Index (53.88%) and CSI 300 (42.07%), while CSI 500 (12.56%) and CSI 2000 (9.09%) were lower [49][52][55] - Price-to-book ratios were analyzed, with current values showing the proportion of stocks trading below their book value. SSE 50 (24.0%), CSI 300 (17.33%), CSI 500 (10.6%), CSI 1000 (7.8%), CSI 2000 (3.2%), and CSI All Share (6.05%) [56]

Investment Rating - The investment rating for the report is "Accumulate (Maintain)" [1] Core Viewpoints - The report highlights that the company has shown robust revenue growth, with a 2025 revenue of 739 million yuan, representing a year-on-year increase of 19.91%. However, the net profit attributable to the parent company decreased by 23.05% to 67 million yuan due to cost pressures [6][10] - The company is focusing on expanding its market presence in Southeast Asia and gradually entering the European and American markets, with projected revenues of 905 million yuan in 2026, growing at a rate of 22.37% [10] - The report emphasizes the increasing market concentration in the konjac product sector, with the company expected to maintain a market share of around 12% in the konjac gel category in 2024, indicating potential for further growth [10] Summary by Relevant Sections Financial Performance - In 2025, the company achieved total revenue of 739 million yuan, with a growth rate of 19.91%. The net profit attributable to the parent company was 67 million yuan, down 23.05% year-on-year [6][10] - The company’s gross margin for 2025 was 19.99%, a decrease of 6.66 percentage points, while the net margin was 9.03%, down 5.03 percentage points [10] - The projected revenues for 2026-2028 are 905 million yuan, 1.087 billion yuan, and 1.268 billion yuan, respectively, with growth rates of 22.37%, 20.17%, and 16.65% [10] Market and Product Insights - The company’s product segments include konjac powder, konjac food, and konjac beauty products, with revenues of 515 million yuan, 213 million yuan, and 3 million yuan, respectively, showing year-on-year growth of 18.74%, 24.38%, and a decline of 37.71% [10] - The company is shifting focus to low-calorie meal replacement foods, plant-based innovations, and tea ingredient markets, while maintaining a strong B2B business model [10] - The company plans to enhance its brand "Molege" through online and local tourism channels, as well as offline distributors [10] Valuation and Investment Recommendations - The current market valuation corresponds to a price-to-earnings ratio (P/E) of 25.9 for 2026, 19.5 for 2027, and 15.9 for 2028, suggesting a favorable investment outlook [10] - The report maintains an "Accumulate" rating based on the anticipated growth in revenue and profitability, despite the recent decline in net profit [10]

Investment Rating - The report assigns an "Accumulate" rating for the company for the first time [1] Core Insights - The company is a leader in the medical sodium hyaluronate dressing market and is actively expanding into class III medical devices [4] - The company has established a diverse product matrix focusing on functional skincare products and class II medical devices, leveraging core technologies of sodium hyaluronate and collagen [16][17] - The online direct sales ratio has been steadily increasing, with significant growth on platforms like Tmall and Douyin [28][33] - The company's stock ownership is highly concentrated, with the chairman holding 84.41% of shares, which enhances operational execution and team stability [34][38] Financial Forecast - The company's total revenue is projected to be 1,823.46 million yuan in 2025, with a year-on-year decline of 9.59%, followed by a recovery to 2,054.34 million yuan in 2026, and 2,259.77 million yuan in 2027 [7][9] - The net profit attributable to shareholders is expected to be 452.41 million yuan in 2025, down 31.57% year-on-year, followed by 502.92 million yuan in 2026 and 539.82 million yuan in 2027 [7][9] - The company's price-to-earnings (P/E) ratios for 2025-2027 are projected to be 27.6, 24.8, and 23.1 times, respectively [7][9] Industry Overview - The professional skincare industry in China has seen significant growth, with the market size for functional skincare products and medical dressings expected to reach 623.0 billion yuan and 253.8 billion yuan by 2026, respectively [52][56] - The market for professional skincare products has grown from 102.5 billion yuan in 2017 to 309.6 billion yuan in 2021, with a compound annual growth rate (CAGR) of 31.8% [52][56] - The competitive landscape in the medical dressing market is fragmented, with the company holding a 10.1% market share, making it the leading brand in the industry [60]

Investment Rating - The report assigns an "Accumulate" rating for the company for the first time [1] Core Viewpoints - The company is a leader in the medical sodium hyaluronate dressing market and is actively expanding its product line to include type III human-derived collagen products [4] - The company has a strong channel advantage, having expanded its medical dressing products from public hospitals to various medical institutions, beauty organizations, and retail pharmacies [9] - The online direct sales ratio has been steadily increasing, from 24.97% in 2020 to an expected 49.67% in 2024, indicating a shift towards e-commerce [9] Financial Forecast - Total revenue is projected to be 1,933.50 million yuan in 2023, with a growth rate of 9.29%, and is expected to reach 2,259.77 million yuan by 2027, with a growth rate of 10.00% [7] - Net profit attributable to the parent company is forecasted to be 749.34 million yuan in 2023, declining to 452.41 million yuan in 2025, before recovering to 539.82 million yuan by 2027 [7] - The company's price-to-earnings (P/E) ratios for 2025-2027 are projected to be 27.6, 24.8, and 23.1 times, respectively [9] Industry Overview - The professional skin care product market in China has grown from 180.5 billion yuan in 2017 to 317.1 billion yuan in 2021, with a compound annual growth rate (CAGR) of 15.1% [48] - The market for functional skin care products and medical dressings is expected to reach 623.0 billion yuan and 253.8 billion yuan, respectively, by 2026 [53] - The competitive landscape in the medical dressing market is fragmented, with the company holding a 10.1% market share, making it the leading brand in the industry [9][61]

Investment Rating - The industry rating is "Overweight" (maintained) [5] Core Insights - The dual drivers of demand from power and energy storage are leading to a temporary shortage in high-pressure lithium iron phosphate (LiFePO4) capacity. High-pressure LiFePO4 refers to lithium iron phosphate cathode materials with a powder density of ≥2.60g/cm³, corresponding to fourth-generation products. Its core value lies in higher energy storage per unit volume, fast charging performance, and cycle life, which directly enhance battery energy density and space utilization, meeting the industry's urgent needs for fast charging in power batteries and large energy storage cells [5] - In the power battery sector, fast charging has become a competitive edge for electric vehicles, with the proliferation of BYD's second-generation blade battery and CATL's second-generation supercharging battery pushing cathode materials towards high-pressure upgrades. The rigid consumer demand for fast charging experience is gradually replacing medium and low-pressure products. In the energy storage sector, super-large capacity cells (over 500Ah) are expected to see large-scale release in 2026, with products like CATL's 587Ah accelerating commercialization [5] - The supply side of lithium iron phosphate faces multiple barriers, with high-end effective capacity being released slowly. According to GGII, over 5.5 million tons of new and under-construction lithium iron phosphate cathode material capacity is planned in China for 2025, with most directed towards the high-pressure segment. The reasons for the slow release of high-end LiFePO4 capacity include high technical barriers, high costs and long cycles for production line upgrades, and customer verification standards that hinder rapid conversion of new capacity into effective supply [5] Summary by Sections - Recent Industry Performance: The industry has shown relative returns of 15.33% over one month, 11.84% over three months, and 47.33% over twelve months compared to the CSI 300 index. Absolute returns were 10.92%, 8.89%, and 62.34% respectively [3] - Investment Recommendations: The report suggests focusing on companies such as Hunan Youneng, Fulian Precision, Wanrun New Energy, Longpan Technology, and Anda Technology [5]

Investment Rating - The investment rating for the industry is "Accumulate" (maintained) [1] Core Insights - The report highlights that the demand for konjac products remains strong, leading to sustained revenue growth for the company [6][9] - The company achieved a revenue of 739 million yuan in 2025, representing a year-on-year increase of 19.91%, while the net profit attributable to shareholders decreased by 23.05% to 67 million yuan [6][9] - The report anticipates continued revenue growth, projecting revenues of 905 million yuan in 2026, with a growth rate of 22.37% [8][9] Financial Performance Summary - The total revenue for the company is forecasted to grow from 739 million yuan in 2025 to 1.268 billion yuan by 2028, with respective growth rates of 19.91%, 22.37%, 20.17%, and 16.65% [8] - The net profit attributable to shareholders is expected to recover from 67 million yuan in 2025 to 142 million yuan by 2028, with growth rates of -23.05%, 30.53%, 32.32%, and 23.00% [8] - The company's gross margin for 2025 was reported at 19.99%, a decrease of 6.66 percentage points year-on-year, primarily due to rising raw material costs [9] Market Position and Strategy - The company focuses on B-end business while also developing its C-end brand "Molege," which is sold through online and local tourism channels [9] - The company plans to deepen its market presence in Southeast Asia and gradually expand into Europe and the United States [9] - The report indicates that the market concentration for konjac products is increasing, with the leading companies experiencing continuous sales growth [9]

Investment Rating - The industry rating is "Overweight" (maintained) [5] Core Insights - The vacuum pump industry is a core general equipment in manufacturing and scientific research, widely used in various sectors such as chemicals, food, home appliances, photovoltaics, optics, lithium batteries, and semiconductors [5][12] - The global vacuum pump market is projected to reach USD 10.5 billion by 2034, with a compound annual growth rate (CAGR) of 4.8% from USD 6.5 billion in 2024 to USD 6.9 billion in 2025 [5][36] - Domestic demand for vacuum pumps is expected to grow significantly due to the rise of new industries and the trend of domestic substitution in the semiconductor sector, driven by international trade protectionism [5][48] Summary by Sections 1. Vacuum Pump Overview - Vacuum pumps are devices that create a vacuum state in containers using mechanical, physical, or chemical methods, essential for various manufacturing and scientific processes [5][12] - The classification of vacuum pumps includes dry pumps (e.g., screw pumps, rotary vane pumps) and wet pumps (e.g., liquid ring pumps) [15][21] 2. Downstream Industry Development - The demand for vacuum pumps is increasing due to the rapid growth of downstream industries such as manufacturing, pharmaceuticals, electronics, and semiconductors [5][42] - The global photovoltaic vacuum pump market is expected to grow from USD 2.35 billion in 2024 to USD 4.2 billion by 2035, with a CAGR of approximately 5.44% [43] 3. Domestic Substitution and Market Opportunities - The domestic substitution trend in the semiconductor sector is gaining momentum, with China's semiconductor equipment spending expected to account for 42% of global spending by 2024, a 35% year-on-year increase [49] - The domestic vacuum pump market is anticipated to maintain long-term growth, benefiting from the upgrading of traditional industries and the development of new industries [49] 4. Related Listed Companies - **Hanbell Precise Machinery**: A leading company in the compressor and vacuum pump sectors, focusing on technological innovation and expanding its product range [50][54] - **Baoshan Precision Machinery**: Established in 2005, the company has expanded its focus from compressors to include vacuum pumps and cutting tools, with a strong emphasis on high-end manufacturing [67]

- The report primarily focuses on tracking and analyzing the performance of broad-based indices in the A-share market, including metrics such as daily returns, moving averages, turnover rates, risk premiums, PE-TTM, dividend yields, and price-to-book ratios [1][2][3] - The turnover rates for various indices on March 23, 2026, were as follows: CSI 2000 (4.59), CSI 1000 (3.51), ChiNext Index (3.2), CSI 500 (2.43), CSI All Share (2.3), CSI 300 (1.0), and SSE 50 (0.52) [3][17] - The daily return distribution analysis revealed that the ChiNext Index exhibited the largest negative kurtosis deviation, while the CSI 500 had the smallest negative kurtosis deviation. Similarly, the ChiNext Index showed the largest negative skewness, and the CSI 500 had the smallest negative skewness [3][23][25] - Risk premium analysis, using the 10-year government bond yield as the risk-free rate, indicated that the ChiNext Index (2.3%) and SSE 50 (0.63%) had relatively high 5-year percentile values, while the CSI 1000 (0.48%) and CSI All Share (0.32%) had lower values [3][28][30] - The PE-TTM analysis showed that the CSI 500 (93.06%) and CSI 1000 (89.17%) had high 5-year percentile values, while the SSE 50 (72.15%) and ChiNext Index (56.12%) had lower values. The ChiNext Index's 5-year percentile value was below its danger threshold of 80% [3][36][39][40] - Dividend yield analysis highlighted that the ChiNext Index (56.45%) and CSI 300 (44.63%) were at relatively high 5-year historical percentile values, while the CSI 2000 (26.53%) and CSI 500 (17.77%) were at lower values [3][47][48][51] - The price-to-book ratio analysis revealed that the current percentage of stocks trading below their book value was as follows: SSE 50 (24.0%), CSI 300 (18.0%), CSI 500 (11.2%), CSI 1000 (8.8%), CSI 2000 (4.2%), and CSI All Share (6.96%) [3][52]

Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage of the stock [1]. Core Insights - The company is a leading player in the tobacco paper industry, entering a new growth phase driven by stable revenue growth and expansion into new markets [3][5]. - The company has a strong market position with a 38.49% market share in the domestic cigarette paper market as of 2024, and it has established partnerships with major international clients [5][21]. - The acquisition of Jin Feng Paper Industry is expected to enhance production capacity and facilitate entry into the cigarette label market, leveraging existing customer relationships [5][47]. - The financial forecasts indicate significant revenue and profit growth, with projected revenues of 31.03 billion, 35.24 billion, and 40.94 billion from 2025 to 2027, respectively [5][21]. Financial Forecasts - Total revenue (in million yuan) is projected to grow from 2,648.08 in 2023 to 4,094.18 in 2027, with a compound annual growth rate (CAGR) of 16.18% [4]. - Net profit attributable to shareholders is expected to increase from 136.16 million in 2023 to 283.71 million in 2027, reflecting a CAGR of 21.45% [4]. - The company's return on equity (ROE) is forecasted to rise from 5.80% in 2023 to 9.14% in 2027 [4]. Company Overview - The company is recognized as a key production base for cigarette auxiliary materials, with a history of over 70 years and a strong focus on research and development in specialty paper [11][12]. - The main business is tobacco industrial paper, which accounted for 65.48% of total revenue as of mid-2025, followed by mechanical gloss paper at 11.75% [12][21]. - The company has a stable ownership structure, with the largest shareholder holding 27.14% of the shares, ensuring consistent management and strategic direction [15]. Market Dynamics - The traditional cigarette market is stable, with a slight increase in production, while the heat-not-burn (HNB) segment is expected to drive new growth opportunities, with a projected CAGR of 10.1% from 2024 to 2029 [5][46]. - The global cigarette paper market is projected to grow at a CAGR of 2.37% from 2024 to 2029, indicating a stable demand environment [43]. - The company benefits from a favorable regulatory environment, as only a limited number of firms are licensed to produce cigarette paper in China, which helps maintain market stability [44].

Investment Rating - The industry rating is maintained as "Overweight" [5] Core Insights - The vacuum pump industry is a core general equipment in manufacturing and scientific research, widely used in various sectors such as chemicals, food, home appliances, photovoltaics, optics, lithium batteries, and semiconductors [5][12] - The global vacuum pump market is projected to reach USD 10.5 billion by 2034, with a compound annual growth rate (CAGR) of 4.8% from USD 6.5 billion in 2024 to USD 6.9 billion in 2025 [5][36] - Domestic demand for vacuum pumps is expected to grow significantly due to the acceleration of domestic substitution in the semiconductor sector, driven by rising international trade protectionism and the push for self-sufficiency in key technologies [5][49] Summary by Sections 1. Vacuum Pump Overview - Vacuum pumps are devices that create a vacuum state in containers using mechanical, physical, or chemical methods, essential for various manufacturing and scientific processes [5][12] - The classification of vacuum pumps includes dry pumps (e.g., screw pumps, rotary vane pumps) and wet pumps (e.g., liquid ring pumps) [15][21] 2. Downstream Industry Development - The demand for vacuum pumps is increasing due to the rapid growth of downstream industries such as manufacturing, pharmaceuticals, electronics, and semiconductors [36][42] - The global pharmaceutical vacuum pump market is expected to grow from approximately USD 0.941 billion in 2023 to USD 1.334 billion by 2030, with a CAGR of 5.2% [40] 3. Domestic Substitution and Market Opportunities - The domestic market for vacuum pumps is expanding, with a notable increase in the localization of semiconductor equipment, where domestic spending is projected to reach 42% of global totals by 2024 [49] - The rise of domestic brands in the vacuum pump market is supported by government policies and the need for self-sufficiency in technology, particularly in the semiconductor sector [48][49] 4. Related Listed Companies - Hanbell Precise Machinery is a leading company in the compressor and vacuum pump sectors, focusing on technological innovation and expanding its product offerings [50][54] - Baoshan Co., Ltd. has diversified its business to include vacuum pumps and cutting tools, leveraging its expertise in compressor technology [67]